PMC:7536913 / 126-358 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":17,"end":25},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"us disease 2019 (COVID‐19) can transform drug development and review. It has exposed vulnerabilities and inadequacies in the global healthcare ecosystem as well as spurred innovation, rapid adaption of novel solutions, and unprecede"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T3","span":{"begin":73,"end":76},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"us disease 2019 (COVID‐19) can transform drug development and review. It has exposed vulnerabilities and inadequacies in the global healthcare ecosystem as well as spurred innovation, rapid adaption of novel solutions, and unprecede"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":41,"end":45},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"us disease 2019 (COVID‐19) can transform drug development and review. It has exposed vulnerabilities and inadequacies in the global healthcare ecosystem as well as spurred innovation, rapid adaption of novel solutions, and unprecede"}

{"project":"LitCovid-PubTator","denotations":[{"id":"7","span":{"begin":17,"end":25},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"tao:has_database_id","subj":"7","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"us disease 2019 (COVID‐19) can transform drug development and review. It has exposed vulnerabilities and inadequacies in the global healthcare ecosystem as well as spurred innovation, rapid adaption of novel solutions, and unprecede"}